These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 10980532)
1. Genotype determination at the survival motor neuron locus in a normal population and SMA carriers using competitive PCR and primer extension. Gérard B; Ginet N; Matthijs G; Evrard P; Baumann C; Da Silva F; Gérard-Blanluet M; Mayer M; Grandchamp B; Elion J Hum Mutat; 2000 Sep; 16(3):253-63. PubMed ID: 10980532 [TBL] [Abstract][Full Text] [Related]
2. SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS. Veldink JH; Kalmijn S; Van der Hout AH; Lemmink HH; Groeneveld GJ; Lummen C; Scheffer H; Wokke JH; Van den Berg LH Neurology; 2005 Sep; 65(6):820-5. PubMed ID: 16093455 [TBL] [Abstract][Full Text] [Related]
3. Determination of SMN1 and SMN2 copy number using TaqMan technology. Anhuf D; Eggermann T; Rudnik-Schöneborn S; Zerres K Hum Mutat; 2003 Jul; 22(1):74-8. PubMed ID: 12815596 [TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of SMN1 and SMN2 genes based on DHPLC: a highly efficient and reliable carrier-screening test. Su YN; Hung CC; Li H; Lee CN; Cheng WF; Tsao PN; Chang MC; Yu CL; Hsieh WS; Lin WL; Hsu SM Hum Mutat; 2005 May; 25(5):460-7. PubMed ID: 15832310 [TBL] [Abstract][Full Text] [Related]
5. Genetic study of SMA patients without homozygous SMN1 deletions: identification of compound heterozygotes and characterisation of novel intragenic SMN1 mutations. Martín Y; Valero A; del Castillo E; Pascual SI; Hernández-Chico C Hum Genet; 2002 Mar; 110(3):257-63. PubMed ID: 11935338 [TBL] [Abstract][Full Text] [Related]
6. Analysis of point mutations in the SMN1 gene in SMA patients bearing a single SMN1 copy. Zapletalová E; Hedvicáková P; Kozák L; Vondrácek P; Gaillyová R; Maríková T; Kalina Z; Jüttnerová V; Fajkus J; Fajkusová L Neuromuscul Disord; 2007 Jun; 17(6):476-81. PubMed ID: 17475491 [TBL] [Abstract][Full Text] [Related]
7. A genetic and phenotypic analysis in Spanish spinal muscular atrophy patients with c.399_402del AGAG, the most frequently found subtle mutation in the SMN1 gene. Cuscó I; López E; Soler-Botija C; Jesús Barceló M; Baiget M; Tizzano EF Hum Mutat; 2003 Aug; 22(2):136-43. PubMed ID: 12872254 [TBL] [Abstract][Full Text] [Related]
8. Population screening and cascade testing for carriers of SMA. Smith M; Calabro V; Chong B; Gardiner N; Cowie S; du Sart D Eur J Hum Genet; 2007 Jul; 15(7):759-66. PubMed ID: 17392705 [TBL] [Abstract][Full Text] [Related]
9. A sensitive assay for measuring SMN mRNA levels in peripheral blood and in muscle samples of patients affected with spinal muscular atrophy. Vezain M; Saugier-Veber P; Melki J; Toutain A; Bieth E; Husson M; Pedespan JM; Viollet L; Pénisson-Besnier I; Fehrenbach S; Bou J; Frébourg T; Tosi M Eur J Hum Genet; 2007 Oct; 15(10):1054-62. PubMed ID: 17609673 [TBL] [Abstract][Full Text] [Related]
10. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Wirth B Hum Mutat; 2000; 15(3):228-37. PubMed ID: 10679938 [TBL] [Abstract][Full Text] [Related]
11. Inverse correlation between SMN1 and SMN2 copy numbers: evidence for gene conversion from SMN2 to SMN1. Ogino S; Gao S; Leonard DG; Paessler M; Wilson RB Eur J Hum Genet; 2003 Mar; 11(3):275-7. PubMed ID: 12673282 [TBL] [Abstract][Full Text] [Related]
12. Implementation of SMA carrier testing in genetic laboratories: comparison of two methods for quantifying the SMN1 gene. Cuscó I; Barceló MJ; Baiget M; Tizzano EF Hum Mutat; 2002 Dec; 20(6):452-9. PubMed ID: 12442269 [TBL] [Abstract][Full Text] [Related]
13. Transmission ratio distortion in the spinal muscular atrophy locus: data from 314 prenatal tests. Botta A; Tacconelli A; Bagni I; Giardina E; Bonifazi E; Pietropolli A; Clementi M; Novelli G Neurology; 2005 Nov; 65(10):1631-5. PubMed ID: 16301493 [TBL] [Abstract][Full Text] [Related]
14. Genetic conversion of an SMN2 gene to SMN1: a novel approach to the treatment of spinal muscular atrophy. DiMatteo D; Callahan S; Kmiec EB Exp Cell Res; 2008 Feb; 314(4):878-86. PubMed ID: 18078930 [TBL] [Abstract][Full Text] [Related]
15. Genetic testing and risk assessment for spinal muscular atrophy (SMA). Ogino S; Wilson RB Hum Genet; 2002 Dec; 111(6):477-500. PubMed ID: 12436240 [TBL] [Abstract][Full Text] [Related]
16. [Quantitative analysis of SMN gene copies in spinal muscular atrophy]. Ding HX; Yang XS; Xiao B; Wu ZG; Zhang LF Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Apr; 21(2):153-5. PubMed ID: 15079799 [TBL] [Abstract][Full Text] [Related]
17. Quantification of SMN1 and SMN2 genes by capillary electrophoresis for diagnosis of spinal muscular atrophy. Wang CC; Chang JG; Ferrance J; Chen HY; You CY; Chang YF; Jong YJ; Wu SM; Yeh CH Electrophoresis; 2008 Jul; 29(13):2904-11. PubMed ID: 18546169 [TBL] [Abstract][Full Text] [Related]
18. Investigation of the role of SMN1 and SMN2 haploinsufficiency as a risk factor for Hirayama's disease: clinical, neurophysiological and genetic characteristics in a Spanish series of 13 patients. Gamez J; Also E; Alias L; Corbera-Bellalta M; Barceló MJ; Centeno M; Raguer N; Gratacós M; Baiget M; Tizzano EF Clin Neurol Neurosurg; 2007 Dec; 109(10):844-8. PubMed ID: 17850955 [TBL] [Abstract][Full Text] [Related]